Advertisement

Approximately 19 million cases of sexually transmitted infections (STIs), occur in the United States each year (1). For sexually active persons, male latex condoms remain the most widely available and commonly used barrier method for prevention of STI (2). When used consistently and correctly, male condoms reduce the risk of pregnancy and most STIs, including HIV, according to results of laboratory and clinical studies. Levels of condom use have continued to increase in recent years, as shown in national surveys of adolescents and adults (3–6), largely in response to the HIV epidemic. Condom use at last intercourse, for example, has now risen to more than 60% among adolescents (4) and adults at risk (6). Moreover, according to the 2002 National Survey of Family Growth (NSFG) (3), more than 13 million reproductive age women currently use condoms for contraception or protection from STIs, an increase from 9 million in the 1995 survey (7). Condom use thus continues to be an important part of public health efforts to prevent acquisition of STIs.

While there is general consensus that condoms must play a central role in any STI/HIV prevention program (8), how strongly condoms should be recommended to sexually active persons and those contemplating sexual activity remains controversial. Despite recent increases in condom use, current levels of use are likely insufficient for effective prevention of STIs. Questions about the effectiveness of condoms for STI prevention have also raised concerns regarding public health recommendations for their use (9–11).

Keywords

Cervical Intraepithelial Neoplasia Pelvic Inflammatory Disease Genital Herpes Sexually Transmit Disease Male Condom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Repro Health. 2004;36:6–10.CrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR. 2006;55(RR-11).Google Scholar
  3. 3.
    Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat. 2005;23:1–160.Google Scholar
  4. 4.
    Centers for Disease Control and Prevention. Youth risk behavior surveillance—United States, 2003. MMWR. 2004;53(SS-2):1–96.Google Scholar
  5. 5.
    Centers for Disease Control and Prevention. Trends in sexual risk behaviors among high school students—United States, 1991–2001. MMWR. 2002;51:856–859.Google Scholar
  6. 6.
    Anderson JE, Wilson R, Doll L, et al. Condom use and HIV risk behaviors among U.S. adults: data from a national survey. Fam Plann Perspect. 1999;31:24–28.PubMedCrossRefGoogle Scholar
  7. 7.
    Abma JC, Chandra A, Mosher WD, et al. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat. 1997;Series 23, Number 9.Google Scholar
  8. 8.
    Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground on preventing sexual transmission of HIV. Lancet. 2004;364:1913–1915.PubMedCrossRefGoogle Scholar
  9. 9.
    Cates W Jr. The NIH condom report: the glass is 90% full. Fam Plann Perspect. 2001;33:231–233.PubMedCrossRefGoogle Scholar
  10. 10.
    Boonstra H. Public health advocates say campaign to disparage condoms threatens STD prevention efforts. The Guttmacher Report on Public Policy. 2003;6:1–3.Google Scholar
  11. 11.
    Gilden D. Condom effectiveness, reviewed, revised, reduxed. Community HIV/AIDS Mobilization Project (CHAMP) HHS Watch; July 2005.Google Scholar
  12. 12.
    National Institute of Allergy and Infectious Diseases. Workshop Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Diseases (STD) Prevention. July 20, 2001. Available at http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.
  13. 13.
    Carey RF, Lytle CD, Cyr WH. Implications of laboratory tests of condom integrity. Sex Transm Dis. 1999;26:216–220.PubMedCrossRefGoogle Scholar
  14. 14.
    Lytle CD, Carney PG, Vohra S, et al. Virus leakage through natural membrane condoms. Sex Transm Dis. 1990;17:58–62.PubMedCrossRefGoogle Scholar
  15. 15.
    Consumer Union: Condoms: Extra protection. Consumer Reports 2005;February.Google Scholar
  16. 16.
    Gallo M, Grimes D, Lopez L, Schulz K. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev. 2006;CD003550.Google Scholar
  17. 17.
    Steiner MJ, Warner L, Stone KM, Cates W Jr. Condoms and other barrier methods for prevention of STD/HIV infection, and pregnancy. In: Holmes KK, Sparling PF, Mardh P-A, eds. Sexually Transmitted Diseases, 4th ed., McGraw-Hill, New York (in press).Google Scholar
  18. 18.
    Centers for Disease Control and Prevention. Nonoxynol-9 spermicide contraception use—United States, 1999. MMWR. 2002;51:389–392.Google Scholar
  19. 19.
    Centers for Disease Control and Prevention. CDC statement on study results of products containing nonoxynol-9. MMWR. 2000;49:717–718.Google Scholar
  20. 20.
    Fihn SD, Boyko EJ, Normand EH, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol. 1996;144:512–520.PubMedCrossRefGoogle Scholar
  21. 21.
    Warner L, Hatcher RA, Steiner MJ. Male Condoms. In: Hatcher RA, Trussell J, Stewart F, Nelson AL, Cates Jr W, Guest F, et al, editors. Contraceptive Technology, 18th ed. New York: Ardent Media Inc., 2004, pp 331–353.Google Scholar
  22. 22.
    ASTM (American Society for Testing Materials). Annual book of ASTM standards: Easton MD: ASTM: section 9, rubber. Volume 09.02 Rubber products; standard specifications for rubber contraceptives (male condoms-D3492). West Conshohocken, PA: American Society for Testing Materials, 1996.Google Scholar
  23. 23.
    Carey RF, Herman WA , Retta SM, et al. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sex Transm Dis. 1992;19:230–234.PubMedCrossRefGoogle Scholar
  24. 24.
    Conant MA, Spicer DW, Smith CD. Herpes simplex virus transmission: condom studies. Sex Transm Dis. 1984;11:94–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Judson FN, Ehret JM, Bodin GF, et al. In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis. 1989;16:51–56.PubMedCrossRefGoogle Scholar
  26. 26.
    Katznelson S, Drew WL, Mintz L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis. 1984;150:155–157.PubMedCrossRefGoogle Scholar
  27. 27.
    Rietmeijer CA, Krebs JW, Feorina PM, et al. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA. 1988;259:1851–1853.PubMedCrossRefGoogle Scholar
  28. 28.
    Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS.. 1987;1:49–52.PubMedGoogle Scholar
  29. 29.
    Lytle CD, Routson LB, Seaborn GB, et al. An in vitro evaluation of condoms as barriers to a small virus. Sex Transm Dis. 1997;24:161–164.PubMedCrossRefGoogle Scholar
  30. 30.
    Warner L, Steiner MJ. Male condoms. In: Hatcher RA, Trussell J, Stewart F, Nelson AL, Cates Jr W, Guest F, et al, eds. Contraceptive Technology, 19th ed. New York: Ardent Media Inc., 2007.Google Scholar
  31. 31.
    Warner L, Stone KM, Macaluso M, et al. A systematic review of design factors assessed in epidemiologic studies of condom effectiveness for preventing gonorrhea and chlamydia. Sex Transm Dis. 2006;33:36–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Stone KM, Thomas E, Timyan J. Barrier methods for the prevention of sexually transmitted diseases. In: Holmes KK, Sparling PF, Mardh P-A, eds. Sexually Transmitted Diseases, 3rd ed. New York: McGraw-Hill, 1998.Google Scholar
  33. 33.
    Ronald AL, Albritton W. Chancroid and Haemophilus ducreyi. In: Holmes KK, Sparling PF, March P-A, et al., eds. Sexually Transmitted Diseases, 3rd Ed. New York: McGraw-Hill, 1999, p. 518.Google Scholar
  34. 34.
    Musher DM. Early syphilis. In: Holmes KK, Sparling PF, March P-A, et al., eds. Sexually Transmitted Diseases, 3rd Ed. New York: McGraw-Hill, 1999, p. 479.Google Scholar
  35. 35.
    Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PF, March P-A, et al., eds. Sexually Transmitted Diseases, 3rd Ed. New York: McGraw-Hill, 1999, p. 295.Google Scholar
  36. 36.
    Barasso R, DeBrux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med. 1987;317:916–923.CrossRefGoogle Scholar
  37. 37.
    Chuang TY, Perry HO, Kurland LT, et al. Condyloma acuminatum in Rochester, Minn, 1950–1978. Arch Dermatol. 1984;120:469–475.PubMedCrossRefGoogle Scholar
  38. 38.
    Hippelainen M, Syrjanen S, Hippelainen M, et al. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis. 1993;20:321–328.PubMedCrossRefGoogle Scholar
  39. 39.
    Kennedy L, Buntine DW, O'Connor D, et al. Human papillomavirus—a study of male sexual partners. Med J Austr. 1988;149:309–311.Google Scholar
  40. 40.
    Krebs HB, Schneider V. Human papillomavirus-associated lesions of the penis: colposcopy, cytology, and histology. Obstet Gynecol. 1987;70:299–304.PubMedGoogle Scholar
  41. 41.
    Schultz RE, Miller JW, MacDonald GR, et al. Clinical and molecular evaluation of acetowhite genital lesions in men. J Urol. 1990;143:920–923.PubMedGoogle Scholar
  42. 42.
    Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis. 2004;189:677–678.PubMedCrossRefGoogle Scholar
  43. 43.
    Nicolau SM, Camargo CG, Stavale JN, et al. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology. 2005;65:251–255.PubMedCrossRefGoogle Scholar
  44. 44.
    Hernandez B, McDuffie K, Goodman M, et al. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clinic Micro. 2006;44:513–517.CrossRefGoogle Scholar
  45. 45.
    Cates W Jr. The condom forgiveness factor: the positive spin. Sex Transm Dis. 2002;29:350–352.Google Scholar
  46. 46.
    Cates W Jr. Contraception, contraceptive technology, and STDs. In: Holmes KK, Sparling PF, Mardh P-A, eds. Sexually Transmitted Diseases, 3rd ed., McGraw-Hill: New York, 1998.Google Scholar
  47. 47.
    Mann JR, Stine CC, Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom. Sex Transm Dis. 2002;29:344–349.PubMedCrossRefGoogle Scholar
  48. 48.
    Aral SO, Peterman TA. Measuring outcomes of behavioural interventions for STD/HIV prevention. Int J STD AIDS. 1996;7(Suppl 2):30–38.PubMedCrossRefGoogle Scholar
  49. 49.
    Gray R, Mawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet. 2001;357:1149–1153.PubMedCrossRefGoogle Scholar
  50. 50.
    Mastro T, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS. 1996;10(suppl A):S75–S82.PubMedCrossRefGoogle Scholar
  51. 51.
    Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol. 1970;91:170–174.PubMedGoogle Scholar
  52. 52.
    Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA. 1983;250:3205–3209.PubMedCrossRefGoogle Scholar
  53. 53.
    Lycke E, Lowhagen GB, Hallhagen G, et al. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis. 1980;7:6–10.PubMedCrossRefGoogle Scholar
  54. 54.
    Plummer FA, D'Costa LJ, Nsanze H, et al. Epidemiology of chancroid and haemophilus ducreyi in Nairobi, Kenya. Lancet. 1983;2:1293–1295.PubMedCrossRefGoogle Scholar
  55. 55.
    Wasserheit JN. Epidemiologic synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;9:61–77.CrossRefGoogle Scholar
  56. 56.
    Shlay JC, McClung MW, Patnaik JL, Douglas JM Jr. Comparison of sexually transmitted disease prevalence by reported condom use: errors among consistent condom users seen at an urban sexually transmitted disease clinic. Sex Transm Dis. 2004;31:526–532.PubMedCrossRefGoogle Scholar
  57. 57.
    Shlay JC, McClung MW, Patnaik JL, Douglas JM Jr. Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sex Transm Dis. 2004;31:154–160.PubMedCrossRefGoogle Scholar
  58. 58.
    Devine OJ, Aral SO. The impact of inaccurate reporting of condom use and imperfect diagnosis of sexually transmitted disease infection in studies of condom effectiveness: a simulation-based assessment. Sex Transm Dis. 2004;31:588–595.PubMedCrossRefGoogle Scholar
  59. 59.
    Paz-Bailey G, Koumans EH, Sternberg M, et al. The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med. 2005;159:536–542.PubMedCrossRefGoogle Scholar
  60. 60.
    Warner L, Macaluso M, Newman DR, et al. Re: Condom effectiveness for prevention of chlamydia trachomatis infection. Sex Transm Inf. 2006;82:265.CrossRefGoogle Scholar
  61. 61.
    Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol. 2005;161:765–773.PubMedCrossRefGoogle Scholar
  62. 62.
    Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol. 2004;159:242–251.PubMedCrossRefGoogle Scholar
  63. 63.
    Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices. Implications for evaluating method and user effectiveness. Sex Transm Dis. 1998;25:273–277.PubMedCrossRefGoogle Scholar
  64. 64.
    Crosby R, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Inf. 2002;78:228–231.CrossRefGoogle Scholar
  65. 65.
    Niccolai L, Rowhani-Rahbar A, Jenkins H, et al. Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Inf. 2005;81:323–325.CrossRefGoogle Scholar
  66. 66.
    Fishbein M, Pequegnat W. Evaluating AIDS prevention interventions using behavioral and biological outcome measures. Sex Transm Dis. 2000;27:101–110.PubMedCrossRefGoogle Scholar
  67. 67.
    Macaluso M, Kelaghan J, Artz L, et al. Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis. 1999;26:450–458.PubMedCrossRefGoogle Scholar
  68. 68.
    Steiner MJ, Feldblum PJ, Padian N. Invited commentary: condom effectiveness—will prostate specific antigen shed new light on this perplexing problem. Am J Epidemiol. 2003;157:298–300.PubMedCrossRefGoogle Scholar
  69. 69.
    Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995;22:15–21.PubMedCrossRefGoogle Scholar
  70. 70.
    Holmes KK, Levine R, Weaver M. Effectiveness of condom in preventing sexually transmitted infections. Bull WHO. 2004;84:454–461.Google Scholar
  71. 71.
    Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis. 2002;29:725–735.PubMedCrossRefGoogle Scholar
  72. 72.
    Aral SO, Peterman TA. A stratified approach to untangling the behavioral/bio-medical outcomes conundrum. Sex Transm Dis. 2002;29:530–532.PubMedCrossRefGoogle Scholar
  73. 73.
    Casper C, Wald A. Condom use and the prevention of genital herpes acquisition. Herpes. 2002;9:10–14.PubMedGoogle Scholar
  74. 74.
    Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2001;3:CD003255.PubMedGoogle Scholar
  75. 75.
    Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303–1312.PubMedCrossRefGoogle Scholar
  76. 76.
    Alfonsi GA, Shlay J. The effectiveness of condoms for the prevention of sexually transmitted diseases. Curr Wom Health Reviews. 2005;1:151–159.CrossRefGoogle Scholar
  77. 77.
    d'oro LC, Parazzini F, Naldi L, et al. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med. 1994;70:410–417.PubMedPubMedCentralGoogle Scholar
  78. 78.
    Centers for Disease Control and Prevention. Report to Congress: Prevention of Genital Human Papillomavirus Infection, January 2004.Google Scholar
  79. 79.
    Calzavara L, Burchell AN, Remis RS, et al. Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol. 2003;157:210–217.PubMedCrossRefGoogle Scholar
  80. 80.
    Rietmeijer CA, Bemmelen RV, Judson FN, et al. Incident and repeat infection rates of chlamydia trachomatis among male and female patients in an STD clinic. Sex Transm Dis. 2002;29:65–72.PubMedCrossRefGoogle Scholar
  81. 81.
    Pequegnat W, Fishbein M, Celentano D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies. Sex Transm Dis. 2000;27:127–132.PubMedCrossRefGoogle Scholar
  82. 82.
    Catania JA, Gibson DR, Chitwood DD, et al. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull. 1990;108:339–362.PubMedCrossRefGoogle Scholar
  83. 83.
    Turner CF, Miller HG. Zenilman's anomaly reconsidered: fallible reports, ceteris paribus, and other hypotheses. Sex Transm Dis. 1997;24:522–527.PubMedCrossRefGoogle Scholar
  84. 84.
    Schachter J, Chow JM. The fallibility of diagnostic tests for sexually transmitted disease: the impact on behavioral and epidemiologic studies. Sex Transm Dis. 1995;22:191–196.PubMedCrossRefGoogle Scholar
  85. 85.
    Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. New Engl J Med. 2006;354:2645–2654.PubMedCrossRefGoogle Scholar
  86. 86.
    Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer. 2003;107:804–810.PubMedCrossRefGoogle Scholar
  87. 87.
    Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillo-mavirus: a randomized clinical trial. Int J Cancer. 2003;107:811–816.PubMedCrossRefGoogle Scholar
  88. 88.
    Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100–3106.PubMedCrossRefGoogle Scholar
  89. 89.
    Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis. 2004;190:1059–1067.PubMedCrossRefGoogle Scholar
  90. 90.
    Wald A, Langenberg AG, Krantz, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143:707–713.PubMedCrossRefGoogle Scholar
  91. 91.
    Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health.. 2004;94:1327–1329.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001;185:380–365.PubMedCrossRefGoogle Scholar
  93. 93.
    Kelaghan J, Rubin GL, Ory HW, Layde PM. Barrier-method contraceptives and pelvic inflammatory disease. JAMA. 1982;248:184–187.PubMedCrossRefGoogle Scholar
  94. 94.
    Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS. 1998;12:1899–1906.PubMedCrossRefGoogle Scholar
  95. 95.
    Rosenberg MJ, Davidson AJ, Chen J-H, et al. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992;82:669–674.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Sanchez J, Campos PE, Courtois B, et al. Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis. 2003;30:273–279.PubMedCrossRefGoogle Scholar
  97. 97.
    Joesoef MR, Linnan M, Barakbah Y, et al. Patterns of sexually transmitted diseases in female sex workers in Surabaya, Indonesia. Int J STD AIDS. 1997;8:576–580.PubMedCrossRefGoogle Scholar
  98. 98.
    Fennema JSA, van Ameijden EJC, Coutinho RA, van Den Hoek A. Clinical sexually transmitted diseases among human immunodeficiency virus-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994. Sex Transm Dis. 1997;24:363–371.PubMedCrossRefGoogle Scholar
  99. 99.
    Ahmed S, Lutalo R, Wawer M, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS. 2001;16:2171–2179.CrossRefGoogle Scholar
  100. 100.
    Finelli L, Budd J, Spitalny KC. Early syphilis. Relationship to sex, drugs, and changes in high-risk behavior from 1987–1990. Sex Transm Dis. 1993;20:89–95.PubMedCrossRefGoogle Scholar
  101. 101.
    Gattari P, Speziale D, Grillo R, et al. Syphilis serology among transvestite prostitutes attending an HIV unit in Rome, Italy. Eur J Epidemiol. 1994;10:683–686.PubMedCrossRefGoogle Scholar
  102. 102.
    Sanchez J, Gutuzzo E, Escamilla J. Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program. Sex Transm Dis. 1998;25:82–89.PubMedCrossRefGoogle Scholar
  103. 103.
    Thomas JC, Stratton S. Sexual transmission. In: Thomas JC, Weber DJ, eds. Epidemiologic Methods for the Study of Infectious Diseases. New York: Oxford University Press, 2001, pp 267–287.Google Scholar
  104. 104.
    Cecil H, Zimet GD. Meanings assigned by undergraduates to frequency statements of condom use. Arch Sex Behav. 1998;27:493–505.PubMedCrossRefGoogle Scholar
  105. 105.
    van Duynhoven YTHP, van de Laar MJW, Schop WA, et al. Different demographic and sexual correlates for chlamydial infection and gonorrhoea in Rotterdam. Int J Epidemiol. 1997;26:1373–1385.PubMedCrossRefGoogle Scholar
  106. 106.
    Walsh TL, Frezieres RG, Peacock K, et al. Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease. Contraception. 2003;67:139–150.PubMedCrossRefGoogle Scholar
  107. 107.
    Zenilman JM, Yuenger J, Gala N, et al. Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: preliminary studies of a potential bio-marker for sexual behavior. Sex Transm Dis. 2005;32:90–94.PubMedCrossRefGoogle Scholar
  108. 108.
    Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception. 1999;59:195–201.PubMedCrossRefGoogle Scholar
  109. 109.
    Golden MR, Manhart LE. Innovative approaches to the prevention and control of bacterial sexually infections. Infect Dis Clin N Am. 2005;19:513–540.CrossRefGoogle Scholar
  110. 110.
    Ward DJ, Rowe B, Pattison H, et al. Reducing the risk of sexually transmitted infections in genitourinary medicine clinic patients: a systematic review and meta-analysis of behavioural interventions. Sex Transm Infect. 2005;81:386–393.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis. 2005;191(Suppl 1):S7–S24.PubMedCrossRefGoogle Scholar
  112. 112.
    Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280:1161–1167.PubMedCrossRefGoogle Scholar
  113. 113.
    O'Donnell CR, O'Donnell L, San Doval A, Duran R, Labes K. Reductions in STD infections subsequent to an STD clinic visit. Using video-based patient education to supplement provider interactions. Sex Transm Dis. 1998;25:161–168.PubMedCrossRefGoogle Scholar
  114. 114.
    The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. Science. 1998;280:1889–1894.CrossRefGoogle Scholar
  115. 115.
    Boyer CB, Barrett DC, Peterman TA, Bolan G. Sexually transmitted disease (STD) and HIV risk in heterosexual adults attending a public STD clinic: evaluation of a randomized controlled behavioral risk-reduction intervention trial. AIDS. 1997;11:359–367.PubMedCrossRefGoogle Scholar
  116. 116.
    DiClemente RJ, Wingood GM, Harrington KF, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. JAMA. 2004;292;171–179.PubMedCrossRefGoogle Scholar
  117. 117.
    Orr DP, Langefeld CD, Katz B P, Caine VA . Behavioral intervention to increase condom use among high-risk female adolescents. J Pediatr. 1996;128:288–295.PubMedCrossRefGoogle Scholar
  118. 118.
    Shain RN, Piper JM, Newton ER, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med. 1999;340:93–100.PubMedCrossRefGoogle Scholar
  119. 119.
    Richens J, Imrie J, Copas A. Condoms and seat belts: the parallels and the lessons. Lancet. 2000;355:400–403.PubMedCrossRefGoogle Scholar
  120. 120.
    Cassell MM, Halperin DT, Shelton JD, Stanton, D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. 2006; 332:605–607.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Kajubi P, Kamya MR, Kamya S, et al. Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda. J Acquir Immune Defic Syndr. 2005;40:77–82.PubMedCrossRefGoogle Scholar
  122. 122.
    Imrie J, Stephenson JM, Cowan FM, et al. A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ. 2001;322:1451–1456.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Smoak ND, Scott-Sheldon LA, Johnson BT, Carey MP. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. J Acquir Immune Defic Syndr. 2006;41:374–384.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Steiner MJ, Cates W Jr, Warner L. The real problem with male condoms is nonuse. Sex Transm Dis. 1999;26:459–462.PubMedCrossRefGoogle Scholar
  125. 125.
    Warner L, Steiner MJ. Condom access does not ensure condom use: you've got to be putting me on. Sex Transm Inf. 2002;78:225.CrossRefGoogle Scholar
  126. 126.
    Cates W Jr, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: What is the best contraceptive approach? Sex Transm Dis. 2002;29:168–174.PubMedCrossRefGoogle Scholar
  127. 127.
    Crosby RA, Sanders SA, Yarber WL, et al. Condom use errors and problems among college men. Sex Transm Dis. 2002;29:552–557.PubMedCrossRefGoogle Scholar
  128. 128.
    Steiner M, Piedrahita C, Glover L, Joanis C. Can condom users likely to experience condom failure be identified? Fam Plann Perspect. 1993;25:220–223,226.PubMedCrossRefGoogle Scholar
  129. 129.
    Albert AE, Warner DL, Hatcher RA, Trussell J, Bennett C. Condom use among female commercial sex workers in Nevada's legal brothels. Am J Publ Health. 1995;85:1514–1520.CrossRefGoogle Scholar
  130. 130.
    Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ.on plastic condom and a latex condom. Contraception. 2001;63:25–31.PubMedCrossRefGoogle Scholar
  131. 131.
    Valappil T, Kelaghan J, Macaluso M, et al. Female condom and male condom failure among women at high risk of sexually transmitted diseases. Sex Transm Dis. 2005;32:35–43.PubMedCrossRefGoogle Scholar
  132. 132.
    Macaluso M, Kelaghan J, Artz L, et al. Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis. 1999;26:450–458.PubMedCrossRefGoogle Scholar
  133. 133.
    Walsh TL, Frezieres RG, Peacock K, et al. Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception. 2004;70:407–413.PubMedCrossRefGoogle Scholar
  134. 134.
    Mukenge-Tshibaka L, Alary M, Geraldo N, Lowndes CM. Incorrect condom use and frequent breakage among female sex workers and their clients. Int J STD AIDS. 2005;16:345–347.Google Scholar
  135. 135.
    Russell-Brown P, Piedrahita C, Foldesy R, et al. Comparison of condom breakage during human use with performance in laboratory testing. Contraception. 1992;45:429–437.CrossRefGoogle Scholar
  136. 136.
    Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse. A review. Sex Transm Dis. 1997;24:11–17.PubMedCrossRefGoogle Scholar
  137. 137.
    Richters J, Kippax S. Condoms for anal sex. In: Mindel A, ed. Condoms. London: BMJ Publishing Group, 2000, pp 132–146.Google Scholar
  138. 138.
    Voeller B, Coulson AH, Bernstein GS, Nakamura RM. Mineral oil lubricants cause rapid deterioration of latex condoms. Contraception. 1989;39:95–102.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Lee Warner
    • 1
  • Katherine M. Stone
  1. 1.Division of Reproductive Health, National Center for Chronic Disease Prevention and Health PromotionCenters for Disease Control and PreventionGeorgiaUSA

Personalised recommendations